Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-06

Clinical Trial Update: Ebselen as an add-on Treatment in Hypo/Mania [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating ebselen as an add-on treatment in bipolar disorder with manic episodes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ebselen (ebselen)

Snippet

Sponsor: University of Oxford | Conditions: Bipolar Disorder, Bipolar Disorder, Manic | Phase 2 | Status: COMPLETED